Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient

Benzer Materyaller

• Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
  Yazar:: Yves‐Marie Pers, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
  Yazar:: Marotte, Hubert, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
  Yazar:: Hubert Marotte, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population
  Yazar:: Hubert Marotte, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
  Yazar:: Pers, Yves-Marie, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)